Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (51-60 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2013
Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathwayDaniel R Premkumar, Esther P Jane, Kimberly A Foster, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 17, 2024
Immunotherapy for pediatric low-grade gliomasIan F Pollack, James Felker, Stephen C Frederico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chainFumiyoshi Okano, Walter J Storkus, William H Chambers, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 20, 2007
Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysisTobey J MacDonald, Ian F Pollack, Hideho Okada, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2005
Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodiesMarie E Beckner, Xuan Chen, Jiyan An, et al.
Pediatric Blood & Cancer|September 13, 2014
Pseudoprogression of low-grade gliomas after radiotherapyRobert P Naftel, Ian F Pollack, Giulio Zuccoli, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2009
Abrogation of mitogen-activated protein kinase and Akt signaling by vandetanib synergistically potentiates histone deacetylase inhibitor-induced apoptosis in human glioma cellsEsther P Jane, Daniel R Premkumar, Steven O Addo-Yobo, et al.
Cancer Gene Therapy|July 2, 2003
Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cellsNorimoto Nakahara, Ian F Pollack, Walter J Storkus, et al.
Neuro-Oncology|April 12, 2012
Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomasCraig Horbinski, Marina N Nikiforova, Jill M Hagenkord, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2014
Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cellsEsther P Jane, Daniel R Premkumar, Alejandro Morales, et al.
Pageof 31

Showing results (51-60 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2013
Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathwayDaniel R Premkumar, Esther P Jane, Kimberly A Foster, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 17, 2024
Immunotherapy for pediatric low-grade gliomasIan F Pollack, James Felker, Stephen C Frederico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chainFumiyoshi Okano, Walter J Storkus, William H Chambers, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 20, 2007
Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysisTobey J MacDonald, Ian F Pollack, Hideho Okada, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2005
Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodiesMarie E Beckner, Xuan Chen, Jiyan An, et al.
Pediatric Blood & Cancer|September 13, 2014
Pseudoprogression of low-grade gliomas after radiotherapyRobert P Naftel, Ian F Pollack, Giulio Zuccoli, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2009
Abrogation of mitogen-activated protein kinase and Akt signaling by vandetanib synergistically potentiates histone deacetylase inhibitor-induced apoptosis in human glioma cellsEsther P Jane, Daniel R Premkumar, Steven O Addo-Yobo, et al.
Cancer Gene Therapy|July 2, 2003
Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cellsNorimoto Nakahara, Ian F Pollack, Walter J Storkus, et al.
Neuro-Oncology|April 12, 2012
Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomasCraig Horbinski, Marina N Nikiforova, Jill M Hagenkord, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2014
Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cellsEsther P Jane, Daniel R Premkumar, Alejandro Morales, et al.
Pageof 31